Related Experiment Videos
Cortical spreading depression modifies components of the inflammatory cascade.
Charlie S Thompson1, Antoine M Hakim
1Neuroscience Research Program, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario.
Molecular Neurobiology
|August 4, 2005
Summary
Cortical spreading depression (CSD) influences brain inflammation after stroke, potentially offering protection. Understanding these inflammatory changes may reveal new therapeutic targets for acute stroke treatment.
Area of Science:
- Neuroscience
- Neuroinflammation
- Ischemic Stroke Research
Background:
- Inflammation plays a complex role in stroke outcomes, with both harmful and beneficial inflammatory mediators.
- Cortical spreading depression (CSD) is a phenomenon known to induce brain tolerance to ischemic injury.
- CSD affects gene expression, including genes related to inflammatory processes.
Purpose of the Study:
- To investigate the relationship between cortical spreading depression (CSD) and the inflammatory response following ischemic stroke.
- To identify specific inflammatory mediators and pathways modulated by CSD that contribute to ischemic tolerance.
- To explore the potential of CSD-induced inflammatory modulation as a therapeutic strategy for acute stroke.
Main Methods:
- Review of existing literature on CSD, neuroinflammation, and ischemic stroke.
- Analysis of gene expression changes induced by CSD in the context of ischemia.
- Correlation of CSD-associated inflammatory changes with neuroprotective effects.
Main Results:
- CSD influences the expression of numerous genes involved in the inflammatory response.
- CSD appears to modulate the inflammatory cascade in a manner that promotes ischemic tolerance.
- Specific inflammatory mediators affected by CSD are likely key to its protective effects.
Conclusions:
- CSD's modulation of the inflammatory response is a significant factor in its neuroprotective effects against ischemic injury.
- Identifying the precise inflammatory pathways influenced by CSD could lead to novel therapeutic targets for stroke.
- Further research into CSD-mediated inflammation may pave the way for new acute stroke treatments.